DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported a loss of $92.5 million in its first quarter.
On a per-share basis, the Dublin-based company said it had a loss of $1.52. Earnings, adjusted for one-time gains and costs, were $1.68 per share.
The results missed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $4.51 per share.
The drugmaker posted revenue of $897.8 million in the period, which also missed Street forecasts. Ten analysts surveyed by Zacks expected $981.4 million.
Jazz expects full-year earnings in the range of $4 to $5.60 per share, with revenue in the range of $4.15 billion to $4.4 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
